Horizon Space Acquisition II Corp. Units to Trade Separately

Biotechnology
Biotechnology
Unit Split
Unit Split

Show Chart?

Load external content from TradingView!

*You can change or withdraw your consent at any time in the footer under Cookies.

Horizon Space Acquisition II Corp. Announces Separate Trading of Units, Shares, and Rights

New York, NY / ACCESSWIRE / February 4, 2025 Horizon Space Acquisition II Corp. (Nasdaq: HSPT), a blank check company, has announced that starting February 5, 2025, holders of its units can opt to trade the ordinary shares and rights separately. The company's initial public offering (IPO) involved 5,750,000 units, including those from the underwriters' over-allotment option.

Units that remain undivided will continue to trade on the NASDAQ Global Market under the symbol "HSPTU." Once separated, the ordinary shares will trade under the symbol "HSPT," and the rights will trade under the symbol "HSPTR." To facilitate this separation, unit holders must instruct their brokers to contact the company's transfer agent, VStock Transfer, LLC.

... Read on — Members only

About SL Science Holding Ltd

SL Bio is a biomedical company focused on developing innovative cellular and gene therapies for cancer treatment and regenerative medicine. Leveraging proprietary technologies and strategic partnerships, the company is advancing next-generation immunotherapies and exosome-based products for both medical and consumer applications. SL Bio’s approach combines scientific expertise with a commitment to improving patient outcomes and addressing unmet needs in healthcare. SL Bio also offers ISO-certified, dermatologically tested cow milk-derived exosome-based products and plant extract products for skin and hair care, with commercial distribution in Asia.

View Company Details

SPAC IPO Calendar
SPAC IPO Events
Scroll to Top